Overcoming Operational Hurdles in a High-Stakes Stroke Trial

Argenica Therapeutics’ Phase 2 acute ischaemic stroke trial faced the challenges of unpredictable patient presentation, narrow treatment windows, and demanding emergency care environments. This resulted in study timelines and data quality being at risk. ProPharma partnered closely with Argenica to bring structure and agility to this complex setting — deploying experienced CRAs, real-time data oversight, and site-focused operational support to stabilize execution and maintain momentum.

Through patient journey mapping, enhanced site communication, and proactive data quality management, ProPharma enabled continuous recruitment without interruption and supported an on-time database lock — delivering meaningful safety and efficacy insights to inform future development.

Learn how ProPharma’s hands-on CRO model transforms operational complexity into clinical success, keeping your programs on track, compliant, and delivering results when it matters most.